Open AccessEffect of ribociclib plus fulvestrant on overall survival in the treatment of advanced breast cancer — updated MONALEESA-3 results
Author(s) -
Roman Dubiański
Publication year - 2022
Publication title -
oncology in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 2
eISSN - 2450-6478
pISSN - 2450-1654
DOI - 10.5603/ocp.2021.0034
Subject(s) - fulvestrant , medicine , placebo , oncology , breast cancer , cancer , chemotherapy , endocrine system , gynecology , surgery , hormone , tamoxifen , pathology , alternative medicine